Table 1.

Clinical manifestations, laboratory findings of AT patients

Patients	Age	Sex	Ataxia (age)	Telangiectasia (age)	Afp	Immunoglobulins
AT01	11	M	−	−		↓IgG
AT02	7	F	+(1.8)	−		↓IgA
AT06	7	M	+	+	↑	↓IgA, ↓IgG, ↑IgM
AT07	5	F	+(1.8)	−	↑	↓IgA, ↓IgG
AT7.1	5	M	+(1.8)	−	↑	↓IgA, ↓IgG
AT08	6	F	+	+	↑	↓IgA, ↓IgG2
AT10	14	M	+(1.3)	+(9,5)	↑	↓IgA, ↓IgG2
AT12	3	M	+(1.4)	+(3)		↓IgG3
AT13	6	F	+(1.4)	+(3)	↑	↓IgA, ↓IgG2
AT15	17	M	+(1.5)	+(7)	↑	↓IgA
AT19	2	M	+(1.2)	−	↑	↓IgG3
AT21	9	F	+		↑	↓IgA
AT23	4	M	+(2.1)	+	↑	↓IgA, ↓IgG
AT24	16	M	+	+	↑	↓IgA
AT26	21	F	+		Norm	Norm
AT27	4	M	+(1.8)	−	↑	↓IgA
AT28	9	M	+	+	↑	↓IgA
AT30	9	F	+(2)	+(6)	↑	↓IgA, ↓IgG2, ↓IgG4
AT31	13	M	+(1.3)	+(2)	↑	↓IgA, ↓IgG2
AT33	3	M	+(1)	+(2)	↑	↓IgA
AT33.1	3	M	+(1)	+(2)	↑	↓IgA
AT34	5	F	+(2)	−	Norm	↓IgA,↓IgG2, ↓IgG3, ↓IgG4
AT35	12	M	+(1.5)	+(8)	↑	↓IgA, ↓IgG2,
AT36	4	M	+(1)	−	↑	↓IgA, ↓IgG2, ↓IgG3, ↓IgG4
AT37	8	F	+	+	↑	↑IgG
AT38	5	M	+	+	↑	↓IgG

F, female; M, male; +, present; –, absent; arrows indicate increase (pointing up)/decrease (pointing down) level of an AFP/immunoglobulin.